Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid ''resistance'' in patients with acute promyelocytic leukemia

Blood

Volumn 79, Issue 2, 1992, Pages 299-303

  Muindi, J ^a   Frankel, S R ^a   Miller Jr , W H ^a   Jakubowski, A ^a   Scheinberg, D A ^a   Young, C W ^a   Dmitrovsky, E ^a   Warrell Jr , R P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD LEVEL; CANCER RECURRENCE; CLINICAL ARTICLE; DRUG RESISTANCE; HUMAN; LEUKEMIA CELL; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0026536835     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v79.2.299.bloodjournal792299     Document Type: Article

References (0)